ORIC Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 05/15/2025 | 6.57 M | $36.68 M | 48.33% | 9.25% |
| BLACKROCK, INC. | 05/02/2025 | 5.44 M | $30.33 M | 6.30% | 7.65% |
| PFIZER INC | 05/13/2025 | 5.38 M | $30.00 M | 0.00% | 7.57% |
| 05/15/2025 | 5.29 M | $29.49 B | 100.00% | 7.44% | |
| ALKEON CAPITAL MANAGEMENT LLC | 05/15/2025 | 4.00 M | $22.34 M | 2.56% | 5.64% |
| COLUMN GROUP LLC | 05/14/2025 | 3.54 M | $19.76 M | 0.00% | 4.98% |
| ECOR1 CAPITAL, LLC | 05/15/2025 | 3.42 M | $19.07 M | 0.00% | 4.81% |
| VANGUARD GROUP INC | 05/09/2025 | 3.22 M | $17.94 M | 0.38% | 4.53% |
| VR ADVISER, LLC | 05/15/2025 | 3.18 M | $17.76 M | -27.58% | 4.48% |
| FMR LLC | 05/12/2025 | 2.48 M | $13.84 M | 0.51% | 3.49% |
| STATE STREET CORP | 05/15/2025 | 2.20 M | $12.26 M | 18.97% | 3.09% |
| NEA MANAGEMENT COMPANY, LLC | 05/14/2025 | 2.20 M | $12.25 M | 40.19% | 3.09% |
| VIVO CAPITAL, LLC | 05/12/2025 | 2.08 M | $11.61 M | 62.81% | 2.93% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 2.06 M | $11.50 M | 74.85% | 2.90% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2025 | 2.03 M | $11.31 M | 39.72% | 2.85% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 2.01 M | $11.20 M | 29.06% | 2.83% |
| COMMODORE CAPITAL LP | 05/15/2025 | 2.00 M | $11.16 M | 0.00% | 2.82% |
| 05/15/2025 | 1.73 M | $9.67 M | 0.00% | 2.44% | |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.41 M | $7.87 M | -63.73% | 1.99% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 1.40 M | $7.81 M | 100.00% | 1.97% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 1.35 M | $7.51 M | -3.52% | 1.90% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.33 M | $7.44 M | 2.92% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.31 M | $7.29 M | 2.13% | 1.84% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 1.02 M | $5.71 M | 7.60% | 1.44% |
| SIREN, L.L.C. | 05/23/2025 | 1.01 M | $5.62 M | 0.00% | 1.42% |
| EUCLIDEAN CAPITAL LLC | 05/15/2025 | 989.41 K | $5.52 M | 0.00% | 1.39% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 05/15/2025 | 819.19 K | $4.57 M | -48.18% | 1.15% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 727.83 K | $4.06 M | 1.48% | 1.02% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 700.00 K | $3.91 M | 100.00% | 0.99% |
| NORTHERN TRUST CORP | 05/13/2025 | 546.75 K | $3.05 M | -1.31% | 0.77% |
| CITADEL ADVISORS LLC | 05/15/2025 | 511.89 K | $2.86 M | 1,305.28% | 0.72% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 509.18 K | $2.84 M | 1,331.12% | 0.72% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 426.90 K | $2.38 M | -41.06% | 0.60% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 408.51 K | $2.28 M | -2.26% | 0.58% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 294.78 K | $1.64 M | 9.18% | 0.42% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 259.80 K | $1.45 M | 130.89% | 0.37% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 255.00 K | $1.42 M | 100.00% | 0.36% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 242.00 K | $1.35 M | 100.00% | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 234.83 K | $1.31 M | -14.05% | 0.33% |
| ATOM INVESTORS LP | 05/15/2025 | 210.71 K | $1.18 M | 174.92% | 0.30% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 203.01 K | $1.13 M | 100.00% | 0.29% |
| CANTOR FITZGERALD, L. P. | 05/15/2025 | 200.00 K | $1.12 M | 780.90% | 0.28% |
| FRED ALGER MANAGEMENT, LLC | 05/16/2025 | 178.72 K | $997.27 K | -18.49% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 178.22 K | $994.45 K | -4.41% | 0.25% |
| MORGAN STANLEY | 05/15/2025 | 168.67 K | $941.18 K | -51.44% | 0.24% |
| 05/12/2025 | 167.50 K | $934.66 K | 100.00% | 0.24% | |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 166.15 K | $927.14 K | -0.68% | 0.23% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 04/10/2025 | 156.64 K | $874.07 K | -3.85% | 0.22% |
| NICHOLAS INVESTMENT PARTNERS, LP | 05/15/2025 | 154.38 K | $861.44 K | 100.00% | 0.22% |
| TD ASSET MANAGEMENT INC | 05/07/2025 | 152.70 K | $852.07 K | 3.32% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ORIC Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 120 institutional investors and hedge funds held shares of ORIC Pharmaceuticals, Inc.. The most heavily invested institutionals were:
SG Americas Securities, LLC: 0
Fortitude Family Office, LLC: 0
Parkside Financial Bank & Trust: 0
True Wealth Design, LLC: 0
Trexquant Investment LP: 0
Corebridge Financial, Inc.: 0
111.50% of ORIC Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 71.66 M shares in the last 24 months. This purchase volume represents approximately $703.71 M in transactions.